Tag: EPGL

Blue Horseshoe Stocks: Options Review & More

Options Updates

Under Armour, Inc. UA – On Thursday, we signaled interest in the UA Weekly $45-48 Calls and as you may recall, on that day we were provided the chance at gains spanning from 42-186% from contracts within the range. We mentioned the following morning that we expected to see further moves out of them. Our assumption proved accurate.

Multi-bag intraday gains were there for the taking, and the trading ranges in some cases exceeded any of the big gains we’d seen on Thursday by a wide margin: 

$45 Calls – Trading Range: .87-2.05 – Max Gain: 136%
$45.50 Calls – Trading Range: .54-1.54 – Max Gain: 185%
$46 Calls– Trading Range:  .20-1.10  – Max Gain: 450%
$46.50 Calls – Trading Range: .10-.57 – Max Gain: 470%
$47 Calls – Trading Range: .02-.20 – Max Gain: 900%

______

Bank of America Corp. BAC  – We were also targeting BAC options last week, namely the BAC 07/15 $15 Calls which we signaled for observation on Wednesday morning. That day we witnessed a low of .51 in those calls, and the performance was quite respectable for the remainder of the week, culminating in a high of .85 on Friday.

We’re going to want to leave this play on our radar, with so much time remaining until their expiration, we may yet see further opportunities arise.

Lithium Corp. LTUM

We also want to make a quick mention of LTUM, which appeared on our watchlist on Friday, and subsequently made a notable move.  The stock traded in a range from .10-.1349, for gains approaching 35%

Adding to the Radar

We took a look around this morning for a few new items of interest as we kick off another trading week, and came up with the following four stocks, three of which are in the biopharma sector. Half are catching our attention with fresh news out this morning, and the other half have attractive features on their charts.

FRESH NEWS:

EP Global Communications, Inc. EPGL

Johnson & Johnson Vision Care, Inc. Secures Exclusive Right of First Negotiation to EP Global Communications, Inc. Ophthalmic Technologies (Mon 7:10AM EDT)

Protea Biosciences Group Inc. PRGB

Protea announces license agreement with Yale (Mon 8:00AM EDT)

_____

INTERESTING CHARTS:

TetraLogic Pharmaceuticals Corp. TLOG  & StemCells Inc. STEM are also going on our watchlist after we’ve identified gaps on both charts in need of filling. We’re going to keep an eye on this pair over the next few sessions and see how it shakes out.

Extended Watchlist:
ADCF, ASUV, AVXL, HMPQ, ROSV, SFOR

Wednesday Afternoon Updates

Abby, Inc. ABBY

This morning, ABBY opened up at .155 as trades were going off at the offer. Following a wave of selling pressure, we unfortunately lost our key level of support, and are now monitoring for a new level of support.

We will watch closely for the selling pressure to ease off, and for the bid to solidify. This morning’s activity does not change ABBY’s status as a bottom-play trading near all-time lows. Our experience with bottom-plays in the past tells us that we need to be patient, and ready for any stir that can turn into the next big run.

Sell-offs can often cause people undue worry, so let’s not forget the exciting happenings with ABBY’s Nebraska oil field projects as outlined in this morning’s report. Any word of progress in that regard could be just the catalyst we are looking for to jumpstart ABBY off of its bottom.

____

Amarantus Biosciences, Inc.  AMBS

We have been talking about AMBS since November 6th. Since that time, the stock has seen a low of .017 (Dec. 3rd), and a subsequent high of .0945 today. That move marks a gain of 456%____

Southridge Enterprises, Inc. SRGE

SRGE has been a topic of discussion for us since September 6th. In that span of nearly three months, we’ve seen the stock trade in a range from .001 (Sept. 17) on up to .0194 (Nov. 26th) for a monster 1840% move. It then dipped back to .0045 before running to .015 for an added 233% rip.

With the type of news we saw out of SRGE today, we wouldnt be surprised to see it retest previous highs:

DALLAS, Dec. 26, 2012 /PRNewswire via COMTEX/ — Southridge Enterprises Inc. (PINKSHEETS: SRGE) (“Southridge” or the “Company”) is excited to announce a new Joint Partner, Kinross (NYSE: KGC), a Major listed Mining Company for its Cinco Minas and Gran Cabrera properties. Southridge’s joint partnership with Kinross, a major NYSE listed gold mining company, is valued at roughly $550,000,000 to $600,000,000. Due to numerous shareholder inquiries Southridge and its Board of Directors felt the need to update the market on its recent announcement named, “Southridge Announces Signed Agreement with Major NYSE Listed Mining Company on Cinco Minas and Gran Cabrera Gold & Silver Mines in Mexico.”

Southridge and its advisers are currently working hand in hand with Kinross to finalize the remaining documents and agreements in order to execute this new joint partnership for its Cinco Minas and Gran Cabrera properties with Kinross. Due to the size and complexity of this transaction we expect to execute this joint partnership with Kinross by Mid-January.
____

Extended Watchlist:
CTIX, EPGL,PAYD, BMSN